BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2011
View Archived Issues
Anchor Therapeutics presents new chemokine CXCR4 receptor agonists
Read More
Clinical investigation of NPSP-558 for hypoparathyroidism updated
Read More
Novel glucocorticoid receptor modulators may have fewer side effects than steroids
Read More
Applied Genetic Technologies receives grant for X-linked retinoschisis gene therapy
Read More
Japanese MHLW adds fenofibrate tablets to NHI price list
Read More
GetGoal-F1 results add to phase III data on lixisenatide in type 2 diabetes
Read More
Pilot trial investigates new protocol for treatment of severe pemphigus
Read More
Phase I data on Ad26.ENVA.01 in HAdV-26-seronegative and -seropositive HIV-1-uninfected adults
Read More
Randomized trial assesses estetrol in women with ER-positive early-stage breast cancer
Read More
Korean university synthesizes new PPAR-beta/delta ligands
Read More
New Mnk inhibitors patented by Boehringer Ingelheim
Read More
Spanish research teams disclose new anticancer cyclic peptides
Read More
New recombinant PEGylated FVIII molecules prepared at Novo Nordisk
Read More
Theraclone Sciences begins phase I trial of TCN-032
Read More
BMS and Ambrx establish partnership for biologics
Read More
Biofrontera submits final documents to address BF-200 ALA NDA
Read More
Zymeworks secures financing for antibody technology and pipeline programs
Read More
Acetylon Pharmaceuticals initiates phase I/IIa ACY-1215 study
Read More
ACT clear to conduct phase I/II stem cell therapy trial in U.K.
Read More
EMA committee recommends extending approval of Levemir
Read More
Shire provides update on ProAmatine in U.S.
Read More
RXi acquires worldwide license for vaccine candidate targeting gynecological cancers
Read More
EMA confirms positive benefit-to-risk balance for Multaq
Read More
ImmunoGen submits IND for anticancer candidate
Read More